Cite
Altoe ML, Marone A, Kim HK, et al. Diffuse optical tomography of the breast: a potential modifiable biomarker of breast cancer risk with neoadjuvant chemotherapy. Biomed Opt Express. 2019;10(8):4305-4315doi: 10.1364/BOE.10.004305.
Altoe, M. L., Marone, A., Kim, H. K., Kalinsky, K., Hershman, D. L., Hielscher, A. H., & Ha, R. S. (2019). Diffuse optical tomography of the breast: a potential modifiable biomarker of breast cancer risk with neoadjuvant chemotherapy. Biomedical optics express, 10(8), 4305-4315. https://doi.org/10.1364/BOE.10.004305
Altoe, Mirella L, et al. "Diffuse optical tomography of the breast: a potential modifiable biomarker of breast cancer risk with neoadjuvant chemotherapy." Biomedical optics express vol. 10,8 (2019): 4305-4315. doi: https://doi.org/10.1364/BOE.10.004305
Altoe ML, Marone A, Kim HK, Kalinsky K, Hershman DL, Hielscher AH, Ha RS. Diffuse optical tomography of the breast: a potential modifiable biomarker of breast cancer risk with neoadjuvant chemotherapy. Biomed Opt Express. 2019 Aug 01;10(8):4305-4315. doi: 10.1364/BOE.10.004305. eCollection 2019 Aug 01. PMID: 31453012; PMCID: PMC6701514.
Copy
Download .nbib